A pilot study of the impact of bacterial and fungal coinfections on mildly ill COVID-19 patients
Canadian Journal of Respiratory Therapy · 12.08.2025 · 61
DOI: 10.29390/001c.142509 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Respiratory Therapy, online erschienen am 12.08.2025. Verfasst von Anastasia Vaganova und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institut of Translational Biomedicine St Petersburg University. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Saint Petersburg State University.
Abstract (Originalsprache)
Background
Coinfections and superinfections significantly impair prognosis in severely ill COVID-19 patients who may develop ventilator-associated pneumonia. However, the role of bacterial and fungal infections and/or lung colonization in patients with moderate COVID-19 who are not on mechanical ventilation remains controversial. Additionally, there is limited data on the impact of coinfections on pneumonia development in vaccinated subjects. To clarify this question, we summarize the data for patients treated in the single infectious department for a moderate form of COVID-19-associated pneumonia.
Methods
We evaluated the association of the medical condition on hospital admission and disease duration with anti- Chlamydophila pneumoniae and anti- Mycoplasma pneumoniae quantitative IgM and sputum culture results in COVID-19 in patients (n=271).
Results
Non-pneumococcal Streptococci were the most frequent bacteria isolated from sputum (70% of the population; only one case of St. pneumoniae ), followed by Candida albicans (15.6% of the population) and Neisseria spp. (13% of the population). Airway colonization with C. albicans and anti- M. pneumoniae IgM seropositivity was significantly associated with a higher CT score, especially in vaccinated patients; meanwhile, fungal pathogen C. albicans colonization was associated with prolonged hospital duration. Airway colonization with C. albicans was associated with slightly longer disease duration.
Conclusion
The results demonstrate that respiratory pathogens, at least M. pneumoniae , can contribute to the risk of COVID-19 onset and/or severity in the vaccinated population. Meanwhile, neither bacterial agents of atypical pneumonia nor lung colonization with opportunistic pathogens are essential for recovery in patients with moderate COVID-19 infection when appropriate treatment is provided.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institut of Translational Biomedicine St Petersburg University.
- Infection Department Luga Intredistrict Hospital.
- Clinic Laboratory North-West Centre for Evidence-Based Medicine.
- Faculty of Pediatry St Petersburg State Pediatric Medical University.
- Faculty of Biology St Petersburg University.
- Hospital St Petersburg University.
ORCID-Profile: Anastasia Vaganova, Andrei Ivanov
Förderung
- Saint Petersburg State University
Zitieren
APA
Vaganova, A., Djulanov, D., Uvarova, M., Zaitseva, D., Safarova, D., & Ivanov, A. (2025). A pilot study of the impact of bacterial and fungal coinfections on mildly ill COVID-19 patients. Canadian Journal of Respiratory Therapy, 61. https://doi.org/10.29390/001c.142509
Vancouver
Vaganova A, Djulanov D, Uvarova M, Zaitseva D, Safarova D, Ivanov A. A pilot study of the impact of bacterial and fungal coinfections on mildly ill COVID-19 patients. Canadian Journal of Respiratory Therapy. 2025;61. doi:10.29390/001c.142509
BibTeX
@article{Vaganova2025,
author = {Vaganova, Anastasia and Djulanov, Danial and Uvarova, Marina and Zaitseva, Diana and Safarova, Diana and Ivanov, Andrei},
title = {A pilot study of the impact of bacterial and fungal coinfections on mildly ill COVID-19 patients},
journal = {Canadian Journal of Respiratory Therapy},
year = {2025},
volume = {61},
doi = {10.29390/001c.142509}
}
EUVIMED